The Relationship of Serum Diabetes Antibodies With the Development of Early Diabetic Retinopathy Findings in Children With Type 1 Diabetes Mellitus

被引:1
|
作者
Korkmaz, Hueseyin Anil [1 ,3 ]
Dogan, Beyza [2 ]
Devebacak, Ali [4 ]
Degirmenci, Cumali [4 ]
Afrashi, Filiz [4 ]
机构
[1] Dept Pediat, Div Pediat Endocrinol, Izmir, Turkiye
[2] Univ Hlth Sci, Izmir Fac Med, Izmir, Turkiye
[3] Dr Behcet Uz Pediat Dis & Surg Training & Res Hosp, Dept Pediat, Div Pediat Endocrinol, Izmir, Turkiye
[4] Ege Univ, Fac Med, Dept Ophthalmol, Izmir, Turkiye
关键词
GLUTAMIC-ACID DECARBOXYLASE; AUTOANTIBODIES; RECOMBINANT; PREVALENCE; DIAGNOSIS; ISOFORM; ASSAY;
D O I
10.3928/01913913-20241121-03
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose:To explore how serum diabetes autoantibodies are related to the development of early diabetic retinopathy in children with type 1 diabetes mellitus. Methods: In this prospective and observational study, 62 patients with type 1 diabetes mellitus who had not yet developed clinical diabetic retinopathy were followed up for at least 5 years. Healthy volunteers aged 10 to 20 years were also included. Insulin, pancreatic islet cells, and glutamic acid decarboxylase (GAD) autoantibodies were measured with an RIA kit at the time of type 1 diabetes mellitus diagnosis. Optical coherence tomography angiography (OCTA) was used to evaluate the foveal avascular zone (FAZ) and parafoveal vascular density (PVD) for the development of early diabetic retinopathy among the groups. Patients'OCTA findings were compared with those of healthy volunteers. The obtained data were analyzed via IBM SPSS Statistics for Windows, version 27.0. Spearman's rank correlation test and regression analysis were performed to determine independent predictors of OCTA and type 1 diabetes mellitus parameters. Results: Eighteen boys and 44 girls with type 1 diabetes mellitus with a median age of 15.6 years (range: 10.08 to 20.88 years) were evaluated. Healthy control participants with a median age of 15.3 years (range: 14.2 to 18.2 years) were also included. The mean FAZ was greater in the type 1 diabetes mellitus group than in the healthy control group (P = .013 and .119, respectively). The mean PVD was significantly lower in the type 1 diabetes mellitus group than in the healthy control group. There was no significant correlation between serum diabetes autoantibodies (GAD and insulin autoantibodies) and FAZ or PVD (FAZ and GAD; r = 0.138, P = .286, FAZ and anti-insulin; r = 0.100, P = .441, PVD and GAD; r =-0.151, P = .24, PVD and anti-insulin; r =-0.087, P = .499). Conclusions: Type 1 diabetes mellitus in children without clinically detectable diabetic retinopathy is associated with impaired retinal microcirculation and irregularities at the FAZ margin. Impaired retinal microcirculation and irregularities were associated with glycated hemoglobin levels in the study group. Thus, studies with larger patient series are needed.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Serum antibodies to collagen type IV and development of diabetic vascular complications in children with type 1 (insulin-dependent) diabetes mellitus: A longitudinal study
    Nicoloff, G
    Baydanoff, S
    Petrova, C
    Christova, P
    VASCULAR PHARMACOLOGY, 2002, 38 (03) : 143 - 147
  • [22] Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
    Schreur, Vivian
    van Asten, Freekje
    Ng, Heijan
    Weeda, Jack
    Groenewoud, Joannes M. M.
    Tack, Cees J.
    Hoyng, Carel B.
    de Jong, Eiko K.
    Klaver, Caroline C. W.
    Klevering, B. Jeroen
    ACTA OPHTHALMOLOGICA, 2018, 96 (05) : 459 - 464
  • [23] LIGHT EFFECT ON DIABETIC RETINOPATHY AND CATARACT DEVELOPMENT IN TYPE 1 DIABETES MELLITUS RAT MODEL
    Shehadeh, N.
    Andrawus, E.
    Perlman, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A91 - A91
  • [24] Psychosocial aspects of mothers of children with type 1 diabetes mellitus: the relationship with diabetic control
    Baykara, Burak
    Akay, Aynur Pekcanlar
    Bober, Ece
    Dogan, Ozlem
    Abaci, Ayhan
    Ozbek, Aylin
    Ergin, Canem
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2012, 13 (01): : 39 - 45
  • [25] Lipoprotein(a) predicts development of diabetic retinopathy in patients with type 2 diabetes mellitus
    Ahn, Y. -B.
    Lim, T. -S.
    Yun, J. -S.
    Cha, S. -A.
    Seok, H.
    Moon, S. -D.
    Ko, S. -H.
    DIABETOLOGIA, 2015, 58 : S520 - S520
  • [26] Lipoprotein(a) predicts the development of diabetic retinopathy in people with type 2 diabetes mellitus
    Yun, Jae-Seung
    Lim, Tae-Seok
    Cha, Seon-Ah
    Ahn, Yu-Bae
    Song, Ki-Ho
    Choi, Jin A.
    Kwon, Jinwoo
    Jee, Donghyun
    Cho, Yang Kyung
    Park, Yong-Moon
    Ko, Seung-Hyun
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (02) : 426 - 433
  • [27] Elevated serum OxLDL is associated with progression of type 2 Diabetes Mellitus to diabetic retinopathy
    Kuppan, Kaviarasan
    Mohanlal, Jithu
    Mohammad, Arif Mulla
    Babu, Kannadasan Anand
    Sen, Parveen
    Das Undurti, Narasimha
    Natarajan, Viswanathan
    Narayanasamy, Angayarkanni
    EXPERIMENTAL EYE RESEARCH, 2019, 186
  • [28] Cystatin C as an Early Marker of Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus
    Hooman, Nakysa
    Roohani, Farzaneh
    Moradi, Sedigheh
    Mobarra, Mehdi
    Najafizadeh, Mehri
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1622 - 1622
  • [29] Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus
    Metwalley, Kotb Abbass
    Farghaly, Hekma Saad
    Gabri, Magda Farghali
    Abdel-Aziz, Safwat Mohamed
    Ismail, Asmaa Mohamed
    Raafat, Duaa Mohamed
    Elnakeeb, Islam Fathy
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2021, 13 (03) : 293 - 299
  • [30] Quantitative evaluation of early retinal changes in children with type 1 diabetes mellitus without retinopathy
    Tekin, Kemal
    Inanc, Merve
    Kurnaz, Erdal
    Bayramoglu, Elvan
    Aydemir, Emre
    Koc, Mustafa
    Kiziltoprak, Hasan
    Aycan, Zehra
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2018, 101 (05) : 680 - 685